Trials / Completed
CompletedNCT00471939
Safety and Efficacy of I-020502 in Meshed Skin Autografting
A Phase II, Multi-Centre, Controlled Study of the Safety and Efficacy of Wound Healing Gel I-020502 (KUR-212) in Patients Undergoing Autologous Meshed Skin Grafting.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Kuros Biosurgery AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II, multi-centre, controlled study comparing the safety and tolerability on wound healing following an application of I-020502 in a concentration of 1μg/mL TG-PDGF.AB versus staples applied in the same patient to burn areas requiring autologous meshed skin grafting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | I-020502 | 1 mcg/mL TG-PDGF.AB |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-12-01
- Completion
- 2009-01-01
- First posted
- 2007-05-10
- Last updated
- 2009-03-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00471939. Inclusion in this directory is not an endorsement.